Air Liquide has acquired Spanish startup DiaLibre, further developing its home healthcare activity in the country.
Specialising in diabetes care, DiaLibre combines personalised therapeutic support programmes and medical follow up for patients using innovative technologies.
The company connects doctors, nurses, dieticians and psychologists with patients in order to offer improved daily support.
This new acquisition in Spain reinforces Air Liquide’s service offering throughout the diabetic patient’s care pathway, from the distribution of medical equipment to the personalised support of diabetic patients.
Air Liquide Healthcare already provides home healthcare services for 1.6 million patients worldwide with chronic diseases and the French corporation is developing new home healthcare models designed to improve their quality of life.
François Jackow, member of the Air Liquide Group’s Executive Committee, supervising Healthcare activities, said, “We are pleased to welcome the DiaLibre teams, recognised for their medical, technological, and digital expertise.”
“This acquisition allows us to complete our offer, which seeks to improve the quality of life for our patients by giving them access to the most appropriate approach based on their profile, which is key for patient’s engagement to his treatment.”
“With this acquisition, it will be possible to test and integrate new complementary care models into our offerings. It also opens up new development prospects for the home healthcare business in Europe.”
Air Liquide has been operating in the Spanish healthcare market for more than 50 years and has been present in diabetes since 2016 via its subsidiary Novalab, which supports patients with type 1 and type 2 diabetes.